Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DYRK2 belongs to a family of protein kinases whose members are presumed to be involved in cellular growth and/or development. Additionally we are shipping DYRK2 Proteins (5) and many more products for this protein.
Showing 10 out of 89 products:
Human Polyclonal DYRK2 Primary Antibody for IHC (p), WB - ABIN391770
Yamashita, Chujo, Tokuishi, Anami, Miyawaki, Yamamoto, Kawahara: Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma. in The Journal of thoracic and cardiovascular surgery 2009
Show all 6 references for ABIN391770
Human Polyclonal DYRK2 Primary Antibody for IHC (p), WB - ABIN657991
Guo, Williams, Schug, Li: DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. in The Journal of biological chemistry 2010
Human Polyclonal DYRK2 Primary Antibody for EIA, WB - ABIN783436
Becker, Weber, Wetzel, Eirmbter, Tejedor, Joost: Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. in The Journal of biological chemistry 1998
Human Polyclonal DYRK2 Primary Antibody for EIA, IHC (p) - ABIN359681
Yamashita, Chujo, Moroga, Anami, Tokuishi, Miyawaki, Kawano, Takeno, Yamamoto, Kawahara: DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. in Anticancer research 2009
Silencing of DYRK2 increases cell proliferation but reverses CAM (show CALM1 Antibodies)-DR in Non-Hodgkin's Lymphoma
DYRK2 may regulate EMT (show ITK Antibodies) through Snail (show SNAI1 Antibodies) degradation in ovarian SA and might be a predictive marker for a favorable prognosis in the treatment of this cancer.
Downregulation of DYRK2 is associated with recurrence in early stage breast cancer.
DYRK2-dependent phosphorylation of pregnane X receptor (show NR1I2 Antibodies) facilitates its subsequent ubiquitination by UBR5 (show UBR5 Antibodies).
DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail (show SNAI1 Antibodies).
DYRK2-mediated phosphorylation of p53 (show TP53 Antibodies) at Ser46 is impaired under hypoxic conditions, suggesting a molecular mechanism underlying chemotherapy resistance in solid tumors.
Data indicate that Dyrk2 phosphorylates TERT (show TERT Antibodies) protein, which is then associated with the EDD (show UBR5 Antibodies)-DDB1 (show DDB1 Antibodies)-VprBP (show VPRBP Antibodies) E3 ligase complex for subsequent ubiquitin-mediated TERT (show TERT Antibodies) protein degradation.
DYRK2 regulates tumor progression through modulation of c-Jun (show JUN Antibodies) and c-Myc (show MYC Antibodies)
The findings indicate that ATM (show ATM Antibodies) controls stability and pro-apoptotic function of DYRK2 in response to DNA damage.
These findings indicate that DYRK2 regulates p53 (show TP53 Antibodies) to induce apoptosis in response to DNA damage.
These results suggest that the phosphorylation of Dpysl2 (show DPYSL2 Antibodies) and Dpysl3 (show DPYSL3 Antibodies) by Cdk5 (show CDK5 Antibodies) and DYRK2 is required for the proper positioning of Rohon-Beard neurons and neural crest cells during neurulation in zebrafish embryos.
DYRK2 belongs to a family of protein kinases whose members are presumed to be involved in cellular growth and/or development. The family is defined by structural similarity of their kinase domains and their capability to autophosphorylate on tyrosine residues. DYRK2 has demonstrated tyrosine autophosphorylation and catalyzed phosphorylation of histones H3 and H2B in vitro. Two isoforms of DYRK2 have been isolated. The predominant isoform, isoform 1, lacks a 5' terminal insert.
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
, dual specificity tyrosine-phosphorylation-regulated kinase 2